knowledge -WSS

knowledge

author：focus 2025-09-06 04:14:19 - browse：2

Illustration of a bear on a red arrow with a bull underneath pushing the arrow upward. -- biotech coverage from STAT — Adobe

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates back to 2021. Instead, biotech stocks have dramatically underperformed the broader market, and the year’s few green shoots are yet to grow into a turnaround.

The closely watched XBI biotech index has fallen more than 10% in 2023, while the S&P 500 rose about 13% in the same period. Privately held companies have struggled to raise new capital without taking a hit to their valuations, and biotech IPOs have been rare in number and inconsistent in return.

The problem, analysts and investors said, is that the generalist investors who steer trillions of dollars of capital have simply soured on biotech. The furor over novel weight loss medicines like Wegovy has largely been a Big Pharma phenomenon, and rising interest rates have steered fund managers away from risky biotech stocks. The sector has gone through boom and bust cycles in the past, and it’s difficult, if not impossible, to predict when the macro winds might change and make biotech as popular as it was in the early days of Covid-19.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： What to know about a major upcoming Wegovy heart health study

focus

WSS

How should state employee insurance handle Wegovy?

A revolution in caring for preterm infants

FDA approves Leqembi, a milestone in Alzheimer’s treatment

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

US intelligence assessment says Iran not currently developing nuclear weapons

Another man arrested in connection with shooting at Kansas nightclub

Wikipedia

knowledge

entertainment

Drug repurposing or repositioning? The language matters

Massive project maps cells in human brain in unprecedented detail

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare to cover more brain scans related to Alzheimer’s drugs

Medicare proposal to cover medical devices draws a mixed reaction

UPS workers' union leader explains what's at stake as strike edges closer

Supreme Court strikes down use of affirmative action

Another man arrested in connection with shooting at Kansas nightclub

Wildfire smoke exposes gaps in outdoor worker protections

Researchers CRISPR chickens in bid to protect them from bird flu

hotspot

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Another man arrested in connection with shooting at Kansas nightclub

Akero's treatment for NASH falls short in cirrhosis study

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

With fresh data, a dynamic duo powers Eli Lilly to new heights

Wellcome Trust names Røttingen as its new CEO

hotspot

focus

focus

Wikipedia